publication venue for
- Atypical Femoral Fractures: Radiographic and Histomorphometric Features in 19 Patients 2014
- Similar proportions of women lose bone mineral density with raloxifene or alendronate treatment 2005
- Bone Densitometry in Premenopausal Women 2004
- A Valid and Precise Semiautomated Method for Quantifying Intermuscular Fat Intramuscular Fat in Lower Leg Magnetic Resonance Images. 23:611-622. 2020
- Change in Quantitative Ultrasound-assessed Speed of Sound as a Function of Age in Women and Men and Association With the Use of Antiresorptive Agents: The Canadian Multicentre Osteoporosis Study. 23:549-560. 2020
- Tools for Enhancement and Quality Improvement of Peer Assessment and Clinical Care in Endocrinology and Metabolism. 22:125-149. 2019
- Does Muscle Atrophy and Fatty Infiltration Plateau or Persist in Chronic Spinal Cord Injury?. 21:329-337. 2018
- Measuring Marrow Density and Area Using Peripheral Quantitative Computed Tomography at the Tibia: Precision in Young and Older Adults and Individuals With Spinal Cord Injury. 21:269-280. 2018
- Investigating the Effects of Motion Streaks on pQCT-Derived Leg Muscle Density and Its Association With Fractures. 21:130-139. 2018
- Densitometer-Specific Differences in the Correlation Between Body Mass Index and Lumbar Spine Trabecular Bone Score. 20:233-238. 2017
- Muscle and Myotendinous Tissue Properties at the Distal Tibia as Assessed by High-Resolution Peripheral Quantitative Computed Tomography. 20:226-232. 2017
- Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. 20:8-24. 2017
- Comparison of Speed of Sound Measures Assessed by Multisite Quantitative Ultrasound to Bone Mineral Density Measures Assessed by Dual-Energy X-Ray Absorptiometry in a Large Canadian Cohort: the Canadian Multicentre Osteoporosis Study (CaMos). 19:234-241. 2016
- The Radiology of Vertebral Fractures in Childhood Osteoporosis Related to Glucocorticoid Administration. 19:81-88. 2016
- A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part III: SD, SEE, LSC Association With Fragility Fractures. 18:408-418. 2015
- A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part II: 1-Yr Change, Long-Term Precision, and Least Significant Change. 18:260-269. 2015
- Response to the Letter to the Editor on “Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX vs CAROC Reporting: Results From a Randomized Controlled Trial”. 18:270-271. 2015
- A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part I: Short-term Precision and Validity. 18:124-135. 2015
- Improving Reliability of pQCT-Derived Muscle Area and Density Measures Using a Watershed Algorithm for Muscle and Fat Segmentation. 18:93-101. 2015
- Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX vs CAROC Reporting: Results From a Randomized Controlled Trial. 17:458-465. 2014
- Normative Data for Multisite Quantitative Ultrasound: The Canadian Multicenter Osteoporosis Study. 17:534-540. 2014
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate (ALN) on Bone Mineral Density (BMD) and Bone Turnover in Perimenopausal Women With Low BMD. 17:425-426. 2014
- Development of Recommendations for Radiologists Regarding the Evaluation and Management of Osteoporosis When Reporting Major Osteoporotic Fractures in Those Over Age 50. 17:420-420. 2014
- Role of Self-Efficacy Based Model of Intervention: Learn Approach in Rehabilitation of Distal Radius Fracture. 17:428-429. 2014
- Heterogeneity in Skeletal Load Adaptation Points to a Role for Modeling in the Pathogenesis of Osteoporotic Fracture. 17:170-176. 2014
- Measuring Apparent Trabecular Structure With pQCT: A Comparison With HR-pQCT. 17:47-53. 2014
- The Prevalence of Aortic Calcification on Vertebral Fracture Assessment Imaging Among Patients With Rheumatoid Arthritis. 17:72-77. 2014
- Measuring Apparent Trabecular Density and Bone Structure Using Peripheral Quantitative Computed Tomography at the Tibia: Precision in Participants With and Without Spinal Cord Injury. 16:139-146. 2013
- Medical Management of Primary Hyperparathyroidism. 16:60-63. 2013
- Supplement on Primary Hyperparathyroidism. 16:3-3. 2013
- Surgical Management of Primary Hyperparathyroidism. 16:48-53. 2013
- Intrarater Reliability of Dual-Energy X-Ray Absorptiometry–Based Measures of Vertebral Height in Postmenopausal Women. 15:405-412. 2012
- Comparison of Cortical Bone Measurements Between pQCT and HR-pQCT. 15:275-281. 2012
- Clinical Risk Factors for Fracture in Diabetes: A Matched Cohort Analysis. 14:416-421. 2011
- FRAX® Bone Mineral Density Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference. 14:223-225. 2011
- Official Positions for FRAX® Bone Mineral Density and FRAX® Simplification. 14:226-236. 2011
- Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture. 14:212-219. 2011
- Asymptomatic Primary Hyperparathyroidism—Commentary on Current Management. 13:321-323. 2010
- Comparison of pQCT-Based Measures of Radial Bone Geometry and Apparent Trabecular Bone Structure Using Manufacturer and In-House-Developed Algorithms. 13:433-440. 2010
- Normative Bone Mineral Density Z-Scores for Canadians Aged 16 to 24 Years: The Canadian Multicenter Osteoporosis Study. 13:267-276. 2010
- Dual-Energy X-Ray Absorptiometry Technical Issues: The 2007 ISCD Official Positions. 11:109-122. 2008
- Failure load of the radius is predicted by measures of radial bone geometry and structure obtained using custom software. 10:S223-S223. 2007
- Recommendations for Bone Mineral Density Reporting in Canada: A Shift to Absolute Fracture Risk Assessment. 10:120-123. 2007
- Standards and Guidelines for Technologists Performing Central Dual-Energy X-Ray Absorptiometry. 10:189-195. 2007
- What is the Number of Older Canadians Needed to Screen by Measurement of Bone Density to Detect an Undiagnosed Case of Osteoporosis? A Population-Based Study From CaMos. 9:413-418. 2006
- Alendronate in Primary Hyperparathyroidism: Efficacy in Men and Pre-Menopausal Women. 9:239-239. 2006
- Effect of Diagnostic Radioisotopes and Radiographic Contrast Media on Measurements of Lumbar Spine Bone Mineral Density and Body Composition by Dual-Energy X-Ray Absorptiometry. 9:91-96. 2006
- Standards for Performing DXA in Individuals With Secondary Causes of Osteoporosis. 9:47-57. 2006
- Similar Proportions of Women Lose Bone Mineral Density With Raloxifene or Alendronate Treatment. 8:273-277. 2005
- A Systematic Review of the Effect of Alendronate on Bone Mineral Density in Men. 8:7-13. 2005
- Lumbar Spine Bone Mineral Density at Diagnosis and During Follow-Up in Children With IBD. 7:290-295. 2004
- Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate. 7:255-261. 2004
- Standards and Guidelines for Performing Central Dual-Energy X-Ray Absorptiometry in Premenopausal Women, Men, and ChildrenA Report From the Canadian Panel† of the International Society of Clinical Densitometry. 7:51-63. 2004
- A 6-Mo Home-Based Exercise Program May Slow Vertebral Height Loss. 6:391-400. 2003
- What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy?. 6:315-322. 2003
- In Vivo Measurement of Apparent Trabecular Bone Structure of the Radius in Women With Low Bone Density Discriminates Patients with Recent Wrist Fracture from Those Without Fracture. 6:35-43. 2003
- Standards and Guidelines for Performing Central Dual X-Ray Densitometry from the Canadian Panel of International Society for Clinical Densitometry. 5:435-445. 2002
- Standards and Guidelines for Performing Central Dual X-Ray Densitometry from the Canadian Panel of International Society for Clinical Densitometry. 5:247-257. 2002
- North American Male Reference Population for Speed of Sound in Bone at Multiple Skeletal Sites. 5:63-71. 2002
- Positive Effect of Etidronate Therapy Is Maintained After Drug Is Terminated in Patients Using Corticosteroids. 4:363-371. 2001
- The Canadian Score™ Questionnaire. 3:269-280. 2000
- Etidronate Therapy in the Treatment and Prevention of Osteoporosis. 3:79-95. 2000
- Etridronate therapy in the treatment and prevention of osteoporosis.. 3:79-95. 2000
- In Vivo Detection of Structural Differences Between Dominant and Nondominant Radii Using Peripheral Quantitative Computed Tomography. 2:413-422. 1999
- Gender Differences in Normal Age-Dependent Patterns of Radial Bone Structure and Density. 2:163-173. 1999
- Evidence-Based Management of Patients with Osteoporosis. 1:395-402. 1998